A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV

NCT03657810 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

349

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Nausea
Vomiting

Interventions

DRUG: CL-108 5 mg
DRUG: Norco
DRUG: Placebo

Sponsor

Charleston Laboratories, Inc